Not available outside of the UK & Ireland.
General description
Inhibitor of bacterial, viral, and mammalian neuraminidases. Ki = 4 µM for influenza virus neuraminidase. Believed to act by binding to the catalytic site of neuraminidase as a transition state analog.
A ganglioside neuraminidase inhibitor that is believed to act by binding to the catalytic site of neuraminidase. Reported to inhibit influenza virus neuraminidase (Ki = 4 µM). Also inhibits bacterial, viral, and mammalian neuraminidases.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Kopitz, J., et al. 1997. Eur. J. Cell. Biol.73, 1.Holzer, C.T., et al. 1993. Glycoconj. J.10, 40.Chong, A.K., et al. 1991. Biochem. Int.24, 165.
Packaging
10 mg in Plastic ampoule
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: